Visceral Leishmaniasis Revealing Undiagnosed Inborn Errors of Immunity

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASILEIRA MEDICINA TROPICAL
Citação
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, v.56, article ID e03222023, 4p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Visceral Leishmaniasis (VL) is a potentially fatal disease and may be associated with primary or acquired immunodeficiencies. There are few reports, in the literature, of inborn errors of immunity. Here, we report two cases of VL as a marker of inborn errors of immunity, namely, GATA2 and RAB27A deficiency. Our data suggest that VL patients should be screened for primary immunodeficiency, particularly in cases of VL relapse.
Palavras-chave
Visceral Leishmaniasis, Primary Immunodeficiency, Cellular immunodeficiency
Referências
  1. Ariffin H, 2014, Med J Malaysia, V69, P193
  2. Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2
  3. Collin M, 2015, BRIT J HAEMATOL, V169, P173, DOI 10.1111/bjh.13317
  4. Hsu AP, 2015, CURR OPIN ALLERGY CL, V15, P104, DOI 10.1097/ACI.0000000000000126
  5. Gonzalez-Granado LI, 2016, J CLIN IMMUNOL, V36, P363, DOI 10.1007/s10875-016-0270-9
  6. Khadem F, 2014, FUTURE MICROBIOL, V9, P901, DOI [10.2217/fmb.14.43, 10.2217/FMB.14.43]
  7. Khalid MB, 2022, PEDIAT ALLERG IMM-UK, V33, DOI 10.1111/pai.13653
  8. Kharkar Vidya, 2007, Dermatol Online J, V13, P17
  9. McCusker Christine, 2011, Allergy Asthma Clin Immunol, V7 Suppl 1, pS11, DOI 10.1186/1710-1492-7-S1-S11
  10. Pagliano P, 2017, J CHEMOTHERAPY, V29, P261, DOI 10.1080/1120009X.2017.1323150
  11. Parvaneh N, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26362
  12. van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556